Search Results

You are looking at 291 - 300 of 1,243 items for :

  • Refine by Access: All x
Clear All
Full access

Jeffrey Allen and Mohammad Jahanzeb

Edited by Kerrin G. Robinson

vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma . Cancer 1999 ; 86 : 1189 – 1197 . 13. Pisters KM Ginsberg RJ Giroux DJ . Induction chemotherapy before surgery for early

Full access

Henry Soo-Min Park

Over the course of the past quarter century, an increasing number of observational studies have been published investigating how surgeon and hospital experience can influence the outcomes of patients undergoing complex surgeries. Early studies

Full access

Ariel Polish and Mary F. Mulcahy

significantly greater 5-year survival rate (36% vs 23%; P =.009) and progression-free survival (hazard ratio for progression, 0.66; P <.001) than the group that underwent surgery alone. Much of the evidence for definitive chemoradiation relates to squamous

Full access

Jilma Patrick and Seema Ahsan Khan

has largely been surgery alone (evaluated in 18 studies), although a few authors have been able to evaluate surgery plus radiotherapy. 30 – 32 The survival outcomes in these retrospective analyses have been the subject of several reviews and meta

Full access

Junmiao Wen and Donglai Chen

different treatment strategies. They found that in cT1–3N2 lung cancer, multimodal treatments tended to provide better 5-year overall survival than surgery alone or concurrent chemoradiotherapy. 1 However, the methodology they used in this study needs to be

Full access

Clifford Ko, Janak Parikh, Irina Yermilov, and James Tomlinson

workload of general surgery . Arch Surg 2004 ; 139 : 423 – 428 . 2. Guralnik JM LaCroix AZ Everett DF Kovar MG . Aging in the eighties: the prevalence of comorbidity and its association with disability . Advance Data 1989 ; 170 : 1 – 8

Full access

Karen Hock and Cari Utendorf

measures with a tape measure and bioimpedance spectroscopy. The patients are referred from their surgical oncologist before surgery and after surgery. Patients are followed for lymphedema surveillance for the first two years following surgery at set time

Full access

Yunyun Liu, KKL Chan, and Hui Zhou

Purpose : Neoadjuvant chemotherapy (NACT) can reduce tumor burden, lower difficulty of surgery in advanced ovarian cancer. However, the option of NACT cycle is still highly controversial. This paper intends to explore whether the number of NACT

Full access

J. Sybil Biermann

-speed burr is preferred in this relatively younger age group over more extensive surgery requiring skeletal reconstruction ( Figure 1 ). The challenge with surgery is to remove as much tumor as possible while leaving the joint intact, she added. However

Full access

Robert J. Morgan Jr.

centimeter residual disease at the completion of the surgery. However, the NCCN Guidelines now state that “maximal effort should be made to remove all gross disease.” Another example is how systemic chemotherapy recommendations have evolved after studies